Vtesse Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $200M

Vtesse General Information

Description

Developer of new drug treatments designed to treat severe and life-threatening diseases. The company's new drug treatments, includes treatment for rare disease Niemann-Pick Disease Type C (NPC), enabling patients with NPC and other lysosomal storage diseases to get treated. It also offers information, resources and support that can be used to better understand NPC and to cope with its impact on lives.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 910 Clopper Road
  • Suite 220 South
  • Gaithersburg, MD 20878
  • United States
Primary Industry
Drug Discovery
Vertical(s)
TMT
Corporate Office
  • 910 Clopper Road
  • Suite 220 South
  • Gaithersburg, MD 20878
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vtesse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 03-Apr-2017 $200M Completed Startup
2. Early Stage VC (Series A) 25-Jul-2016 Completed Clinical Trials - Phase 2
1. Accelerator/Incubator Completed Clinical Trials - Phase 2
To view Vtesse’s complete valuation and funding history, request access »

Vtesse Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Vtesse’s complete cap table history, request access »

Vtesse Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of new drug treatments designed to treat severe and life-threatening diseases. The company's new drug treatmen
Drug Discovery
Gaithersburg, MD
10 As of 2017

Wayne, PA

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vtesse Competitors (38)

One of Vtesse’s 38 competitors is Ralexar Therapeutics, a Venture Capital-Backed company based in Wayne, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ralexar Therapeutics Venture Capital-Backed Wayne, PA
Voyager Therapeutics Formerly VC-backed Lexington, MA
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
NeuroNascent Venture Capital-Backed Clarksville, MD
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
You’re viewing 5 of 38 competitors. Get the full list »

Vtesse Patents

Vtesse Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016276774-A1 Hydroxypropyl beta-cyclodextrin compositions and methods Inactive 10-Jun-2015
CA-2988529-A1 Hydroxypropyl beta-cyclodextrin compositions and methods Inactive 10-Jun-2015
EP-3307278-A1 Hydroxypropyl beta-cyclodextrin compositions and methods Inactive 10-Jun-2015
EP-3307278-A4 Hydroxypropyl beta-cyclodextrin compositions and methods Inactive 10-Jun-2015
US-20160361345-A1 Hydroxypropyl beta-cyclodextrin compositions and methods Inactive 10-Jun-2015 A61K31/724
To view Vtesse’s complete patent history, request access »

Vtesse Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vtesse Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Bay City Capital Venture Capital Minority
Cydan Accelerator/Incubator Minority
Lundbeckfonden BioCapital Venture Capital Minority
New Enterprise Associates Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Vtesse FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process